RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Terns Pharmaceuticals Stock

Terns Pharmaceuticals Equity 2024

Terns Pharmaceuticals Equity

255.37 M USD

Ticker

TERN

ISIN

US8808811074

WKN

A2QNWR

In 2024, Terns Pharmaceuticals's equity was 255.37 M USD, a -7.78% increase from the 276.9 M USD equity in the previous year.

Terns Pharmaceuticals Aktienanalyse

What does Terns Pharmaceuticals do?

Terns Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Terns Pharmaceuticals's Equity

Terns Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Terns Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Terns Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Terns Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Terns Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Terns Pharmaceuticals stock

What is the equity of Terns Pharmaceuticals this year?

Terns Pharmaceuticals has equity of 255.37 M USD this year.

What was the equity of Terns Pharmaceuticals compared to the previous year?

The equity of Terns Pharmaceuticals has increased/decreased by -7.78% decreased compared to the previous year.

What impact does a high equity have on investors of Terns Pharmaceuticals?

A high equity is advantageous for investors of Terns Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Terns Pharmaceuticals?

A low equity can be a risk for investors of Terns Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Terns Pharmaceuticals affect the company?

An increase in equity of Terns Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Terns Pharmaceuticals affect the company?

A reduction in equity of Terns Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Terns Pharmaceuticals?

Some factors that can affect the equity of Terns Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Terns Pharmaceuticals so important for investors?

The equity of Terns Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Terns Pharmaceuticals take to change the equity?

To change equity, Terns Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Terns Pharmaceuticals pay?

Over the past 12 months, Terns Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Terns Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Terns Pharmaceuticals?

The current dividend yield of Terns Pharmaceuticals is .

When does Terns Pharmaceuticals pay dividends?

Terns Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Terns Pharmaceuticals?

Terns Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Terns Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Terns Pharmaceuticals located?

Terns Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Terns Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Terns Pharmaceuticals from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did Terns Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of Terns Pharmaceuticals in the year 2023?

In the year 2023, Terns Pharmaceuticals distributed 0 USD as dividends.

In which currency does Terns Pharmaceuticals pay out the dividend?

The dividends of Terns Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Terns Pharmaceuticals

Our stock analysis for Terns Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Terns Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.